BRCA1-mutated patients have a lifetime risk of developing BC of 65% and an ovarian cancer risk of 39%, while the risk of BC is 45% and the risk of ovarian cancer is 17% in BRCA2-mutated patients [26]. The gene discussed is BRCA2; the disease is ovarian carcinoma.